Bon策 Medical Unveils China's First Hairo Robotic Hair Transplant System – Pioneering Standardized, Intelligent, and Precision-Driven Solutions for Over 250 Million Affected by Hair Loss

In China, hair loss has become a health challenge affecting more than 250 million people, among whomAndrogenetic AlopeciaMost common, with an increasingly younger patient demographic. In the face of continuously growing treatment demand, traditional hair transplant surgery has alwaysStruggling to Break Through the Limitations of a Model Centered on "Manual Operations"—Its efficacy is highly dependent on the surgeon’s experience, physical stamina, and intraoperative condition, making it difficult to maintain consistent surgical precision and follicle survival rates, let alone achieve standardized reproducibility. Meanwhile, issues such as the prolonged training cycle for senior physicians and the uneven distribution of high-quality medical resources further constrain the accessibility and efficiency of the industry.

Amid the contradiction between demand and supply, technological innovation has become the key breakthrough point. Transforming hair transplantation from a procedure heavily reliant on“Artisan”The transformation of individual experiential medical skills intoQuantifiable, Replicable, Standardizableprecision medicine workflows have become a key direction for industry evolution.

In January 2025, Bangce Medical's independently developedHairo Hair Transplant Surgical RobotOfficially ObtainedNational Medical Products Administration (NMPA) Class III Medical Device Registration Certificate, and was the first to be introduced into clinical practice, marking China's entry into a new era in the field of hair transplantation.Standardization, Precision, and IntelligenceA New Stage of Development.

Hairo Hair Transplant Surgical Robot IntegrationStereoscopic Vision Recognition System, Intelligent Cloud Brain Hub, High-Precision Force-Controlled Robotic ArmThree Core Underlying Technologies, Achieving“Follicle Identification—Path Planning—Precision Extraction”a full-process closed-loop system. This system eliminates the reliance on surgeons’ individual “hand-eye coordination” in critical surgical steps, establishing a new standard for hair transplantation procedures through stable, controllable algorithms and a precision execution framework.

February 5 (Thursday) 16:00, Artery New Product Review Issue 136, featuringZhang Zhaodong, Founder of Bangce Medical; Chen Yuxin, CMO of Bangce Medical, and share in-depth technical details and industry value of the "Hairo Hair Transplant Surgical Robot."

Hairo Hair Transplant Surgical Robot

· AI Smart Eye:Equipped with cutting-edge AI algorithms, the binocular stereo ultra-high-definition camera achieves a recognition accuracy exceeding 1/10th the diameter of a human hair; its proprietary infrared透视 technology eliminates visual blind spots during surgery.

· AI Smart Brain:Millisecond-level global automatic extraction planning, real-time intelligent puncture navigation, depth control, and path adjustment achieve three goals at once. AI strategizes to make surgery twice as effective with half the effort.

· AI 3D Digital Twin Modeling:Leveraging AI algorithms and a binocular vision system, 3D modeling reconstructs the three-dimensional structure of hair follicles at a 1:1 scale, providing accurate data for surgical procedures. Proprietary micro-needles combined with tensioners: 0.8–1 mm extraction micro-needles achieve over 30% significant wound retraction and reduce the recovery period by more than 50%.

· AI-Powered Smart Arm:Imported state-of-the-art robotic arms perform optimal extraction in real time, intelligently and precisely at second-level speed, effortlessly achieving 1800+ FU/h.

· AI Safety System:Hand-eye coordinated control of the robotic arm enables dynamic trajectory adjustment, millisecond-level anomaly response, real-time compensation for patient movement errors, and real-time force feedback during needle insertion, ensuring utmost surgical safety.

Scan the QR code on the poster to reserve your spot for the live broadcast

Zhang Zhaodong

Pangce Medical Founder

Formerly served as Dean of the Central Research Institute at Harbin Gongzhi Intelligent Technology Co., Ltd. (000584.SZ) and Director of Service Robot R&D at HRG Group (Harbin Institute of Technology Robotics). He was among the earliest professionals in China to obtain certification as a technology manager in the fields of robotics and healthcare, during which period he received the Second Prize for Provincial and Ministerial Level Scientific and Technological Progress. He has extensive expertise in robotic technology R&D, product line development management, and the establishment and certification of mass production systems. He led successful technology transfers for multiple top-tier research institutes. As a member of the National Overall Committee for Artificial Intelligence and Robotics Standards, he participated in the drafting and formulation of numerous national standards. He holds over 200 authorized patents related to robotics intellectual property.

Chen Yuxin

Pound Strategy Medical CMO

Former Vice President of Kans, a pioneer in China’s WeChat-based social commerce sector, who set a monthly sales collection record of RMB 270 million. Founder of Hair Planet, with over five years of deep engagement in the hair health industry. He has initiated nearly 100 academic conferences in the hair care sector and possesses extensive experience in managing physician IP brands and alopecia patient operations, backed by robust resources in medical aesthetics and hair transplant distribution channels.

Pangce Medical, founded in Shanghai in 2019, inherits the technological DNA of Harbin Institute of Technology’s robotics system. With intelligent hair transplant surgical robots at its core, the company is redefining the boundaries of hair diagnosis and treatment. Going beyond surgery, Pangce aims to build a full-cycle medical solution for hair health covering [Technological Hair Transplantation · Scientific Hair Care · Intelligent Hair Protection], striving to become the leader in smart diagnosis and treatment within China’s hair health sector. We pioneer the triple integration of “AI + Image + Robot,” and have accumulated nearly 100 core patents to date.

In 2022, Pangce Medical was honored with titles such as Shanghai’s “Specialized, Refined, Differential, and Innovative” Enterprise. It has secured multiple rounds of investment from leading firms including Shenzhen Capital Group, GSR Ventures, and Lenovo Capital, while simultaneously attracting support from government funds in Shanghai, Guangzhou, Hefei, Wuxi, and other regions. This achievement has realized a dual-drive model of “industry + capital,” helping Chinese intelligent manufacturing emerge prominently on the global technology stage.

“Artery New Product Showcase” is a live-streaming series dedicated to supporting medical enterprises in launching their innovative products. The program’s mission is to facilitate the milestone launch of every innovative medical product. Companies with plans to release innovative medical products or achieve significant milestones and wish to participate in the “Artery New Product Showcase” are invited to add our assistant for consultation.